Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.36 | -23.41 |
PEG Ratio (TTM) | -0.18 | 15.22 |
P/S Ratio (TTM) | 1,044.28 | 50.19 |
P/B Ratio (TTM) | 4.32 | 18.75 |
P/FCF Ratio (TTM) | -3.56 | -3.82 |
Price to 5YR AVG Earnings Ratio | N/A | -3.63 |
Price to 5YR AVG FCF Ratio | N/A | -9.39 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -112.52% | -5.51% |
ROE (TTM) | -214.20% | 15.68% |
Net Profit Margin (TTM) | -33,332.57% | -2,035.83% |
ROIC 5YR AVG | N/A | 14.56% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.21% | -139.36% | N/A |
Revenue | -25.00% | 180.54% | N/A |
Net Income | -12.33% | -149.92% | N/A |
Cash Flow | -11.39% | -168.67% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.84 | 6.23 |
Quick Ratio (TTM) | 2.84 | 5.95 |
D/E Ratio (TTM) | 0.06 | -15.66 |
Interest Coverage (TTM) | 143.74 | -1.78 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 14.20 |
LTL to 5YR AVG FCF | N/A | 0.17 |
Shares Outstanding Growth 5YR AVG | N/A | 125.48% |